Cyclerion Therapeutics Inc (CYCN)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
15,729,300
EV to revenue ratio (TTM)
7.69
EV to ebitda
0.563
Financial Performance
Revenue (TTM)
1,900,000
Gross profit (TTM)
303,000
EBITDA
-9,582,000
Profitability
Operating margin (TTM)
-359.20%
Profit margin
0.00%
Return on assets (TTM)
-52.30%
Return on equity (TTM)
-98.20%
Per Share Metrics
Revenue per share (TTM)
3.43
EPS
-11.62
Diluted EPS (TTM)
-11.62
Book value
8.37
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
8.28
Price to book ratio (TTM)
3.147
Growth
Quarterly earnings growth (YoY)
-43.20%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
1.755